TechNavio's analysts forecast the
Global Parkinson's Disease market to grow at a CAGR of 1.67 percent over the
period 2012-2016. One of the key factors contributing to this market growth is
the rise in the aging population. The Global Parkinsons Disease market has also
been witnessing the transition toward using drugs that have new mechanisms of
action. However, weak pipeline landscape could pose a challenge to the growth
of this market.
TechNavio's report, the Global
Parkinson's Disease Market 2012-2016, has been prepared based on an in-depth
market analysis with inputs from industry experts. The report covers the market
in the Americas, and the EMEA and APAC regions; it also covers the Global
Parkinson's Disease market landscape and its growth prospects in the coming
years. The report also includes a discussion of the key vendors operating in
this market.
The key vendors dominating this
space include GlaxoSmithKline plc, Novartis AG, Orion Corp., and Teva Pharmaceuticals
Industries Ltd.
The other vendors mentioned in the
report are AbbVie Inc., Acadia Pharmaceuticals Inc., Avicena Group Inc.,
BoehringerIngelheim GmbH, Impax Laboratories Inc., Lundbeck A/S, Newron
Pharmaceuticals SpA, Solvay Pharmaceuticals Inc., and Valeant International
SRL.
Key questions answered in this
report:
* What will the market size be in
2016 and what will be the growth rate?
* What are key market trends?
* What is driving this market?
* What are the challenges to market
growth?
* Who are the key vendors in this
market space?
* What are the market opportunities
and threats faced by key vendors?
* What are the strengths and
weaknesses of each of these key vendors?
You can request one free hour of our
analysts time when you purchase this market report. Details provided within the
report.
To order this report:
Email: support@researchonglobalmarkets.com
US:
+1 866 325 7446
UK: +44 203 514 2363
India: +91 22 4098 7600
SOURCE: Researchonglobalmarkets.comRELATED VIDEO:
